MedTrace Logo

Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly

NCT01048567 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2013-12-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether Lactobacillus acidophilus/rhamnosus complex is effective in the prevention of antibiotic-associated diarrhea (AAD) in the elderly.

Conditions

Interventions

OTHER

Lactobacillus acidophilus/rhamnosus

2 capsules (at least 2 billion cells per capsule) three times daily for duration of antibiotic therapy

OTHER

Placebo

2 capsules three times daily for entire duration of antibiotic therapy.

Sponsors & Collaborators

  • Jamieson Laboratories Ltd, Canada

    collaborator UNKNOWN

  • Canadian Society of Hospital Pharmacists

    collaborator OTHER

  • Vancouver Island Health Authority

    lead OTHER

Principal Investigators

  • Curtis Harder, BSc. Pharm, ACPR, Pharm D · Vancouver Island Health Authority

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01048567 on ClinicalTrials.gov